Intellia Therapeutics Congress Trades
NASDAQ: NTLAHealth CareBiotechnology: In Vitro & In Vivo Diagnostic SubstancesUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Last 12 months
- Purchases
- 0
- Sales
- 0
- Politicians trading
- 0
- Latest trade
- Aug 25, 2023
Intellia Therapeutics Congress trading summary
Members of Congress have disclosed 12 transactions in Intellia Therapeutics (NTLA) stock, reported by 2 politicians. No NTLA trades were reported with a transaction date in the past 12 months. The most active traders are Rep. Donald S. Beyer, Jr. (9), Sen. Thomas R. Carper (3).
The latest reported trade is a sale by Thomas R. Carper dated Aug 25, 2023 and disclosed on Sep 5, 2023. The most common reported amount is $1,001 – $15,000; disclosures list value ranges, not exact amounts.
Summary generated from market data by MetaCap's automated system. Methodology
Politicians trading NTLA
NTLA trades by members of Congress
Source: House Clerk and Senate EFD public disclosures. Trades are reported as dollar ranges and may be disclosed up to 45 days after the transaction.
Related
Source: House Clerk and Senate EFD public disclosures. Trades are reported as dollar ranges and may be disclosed up to 45 days after the transaction. Disclosures are shown as filed and are not a recommendation to buy or sell NTLA. How Congress trading data works